VHB937 efficacy and safety in people with ALS: Primary results from the double-blind, randomized, placebo-controlled phase 2 ASTRALS trial (ALS-MND 2026) - Oct 9, 2026 - Abstract #C4; Pres time: Dec 9, 2026; 11:00 AM - 11:15 AM; No abstract available
Clinical • P2 data
|